Biomedtech News

March 28, 2022

Caranx Medical announces the signature of an exlusive Worldwide license with Stanford and UC Santa Barbara universities and a €2M financing from Bpifrance

March 23, 2022

Carbios Featured in the Financial Times as a Game Changing Technology

March 17, 2022

Abivax reports 2021 financial results and operations update

March 11, 2022

Abivax reports promising abx464 phase 2a one-year maintenance results in rheumatoid arthritis

February 25, 2022

Interview of Philippe Pouletty by Hedwige Chevrillon in "Le Grand Journal de l'Éco" on BFM Business TV

February 16, 2022

France 2030 : Truffle Capital is on board with Spikimm

January 12, 2022

Abivax selected for a presentation at the 40th Annual J.P. Morgan Healthcare Conference

December 2, 2021

Abivax receives FDA feedback with guidance on advancing ABX464 into phase 3 clinical testing in ulcerative colitis

December 1, 2021

Abivax's drug-candidate ABX196, shows good tolerability and promising signals of clinical benefit in liver cancer

October 19, 2021

ABX464 shows excellent long-term efficacy data in Abivax's phase 2B maintenance trial in ulcerative colitis

September 24, 2021

Abivax presents first-half 2021 financial results and operations update

September 15, 2021

Abivax provides an update on the ABX464 clinical data and development strategy in ulcerative colitis

Pages

1
2
3
4
5
6
7
8
9